Last reviewed · How we verify
ALPHA-PINENE
At a glance
| Generic name | ALPHA-PINENE |
|---|---|
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Dizziness
- Anxiety
- Nausea
- Tachycardia
- Lightheaded
- Fatigue
Key clinical trials
- Behavioral Pharmacology of THC and Alpha-pinene (PHASE1)
- Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ALPHA-PINENE CI brief — competitive landscape report
- ALPHA-PINENE updates RSS · CI watch RSS